The optimal functional status of the neuroendocrine pathway that controls growth and metabolism, specifically encompassing the Hypothalamus, Pituitary gland, and their downstream target, the liver, which produces Insulin-like Growth Factor-1 (IGF-1). Health in this axis implies a robust, pulsatile secretion of Growth Hormone (GH) and appropriate tissue responsiveness to both GH and IGF-1. This axis is paramount for body composition, tissue repair, and overall metabolic vitality.
Origin
This term is fundamental to endocrinology, describing the primary regulatory system for postnatal growth and adult metabolism. The “axis” concept highlights the hierarchical and interconnected nature of the signaling pathway, from the brain’s regulatory signals to the peripheral effects. Declining health in this axis is characteristic of somatopause, the age-related reduction in GH secretion.
Mechanism
The hypothalamus releases Growth Hormone-Releasing Hormone (GHRH) and somatostatin, which dynamically regulate GH release from the pituitary. GH then acts on target tissues, driving the synthesis of IGF-1, which mediates many of the anabolic effects. Maintaining axis health involves supporting the pulsatility of GH release and ensuring peripheral tissue sensitivity to IGF-1, often through lifestyle and targeted secretagogue interventions.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.